Kinetics of anti-fibrillin-1 autoantibodies in MCTD and CREST syndrome

Ingrid Lundberg, Stefan Antohi, Ken Takeuki, Frank Arnett, Gunter Steiner, Teodor Doru Brumeanu, Lars Klareskog, Constantin Bona*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

14 Scopus citations


Using a highly sensitive Radioimmunoassay (RIA), the kinetics of synthesis of anti-fibrillin (Fbn-1) autoantibodies were studied in 17 patients with mixed connective tissue disease (MCTD) and two with CREST syndrome calcinosis, Raynaud's oesophageal dismotility, sclerodectyly and teleangiectasis who were found to be positive for this autoimmune response. IgG autoantibodies specific for recombinant Fbn-1 (rFbn-1) (aa 369-425) were found in all patients excepting one with MCTD, multiple sclerosis, and dermatomyositis. IgM were found in fewer cases. Several kinetics patterns of anti-Fbn-1 autoantibodies were observed: a) long lasting persistence of IgG and IgM autoantibodies up to 14 years; b) fluctuation of antibodies during various periods up to 16 years; c) disappearance of antibody response after several years, and d) patients producing IgG but not IgM autoantibodies. No differences in the synthesis of autoantibodies were observed between MCTD patients with a stable disease, and those developing during the course features of systemic sclerosis (SSc), Sjogren's syndrome, or rheumatoid-like arthritis. In one patient displaying a lupus-like syndrome for 3 years, the appearance of anti-Fbn-1 autoantibodies coincided with the occurrence of MCTD and scleroderma. While the detection of anti-Fbn-1 autoantibodies may be clinically useful in differential diagnosis or eventual prognosis of patients with connective tissue diseases, their role in the pathogenesis of scleroderma syndromes requires further investigation. (C) 2000 Academic Press.

Original languageEnglish
Pages (from-to)267-274
Number of pages8
JournalJournal of Autoimmunity
Issue number3
StatePublished - 2000
Externally publishedYes


  • Autoantibodies
  • CREST syndrome
  • Fibrillin-1
  • Kinetics
  • MCTD


Dive into the research topics of 'Kinetics of anti-fibrillin-1 autoantibodies in MCTD and CREST syndrome'. Together they form a unique fingerprint.

Cite this